Variable | Least Overlap (N = 520) | Most Overlap (N = 131) | P Value |
Age (y), mean (range) | 60.30 (24–88) | 63.90 (26–87) | 0.001 |
Gender, n (%) | 0.96 | ||
Male | 225 (43.3%) | 57 (43.5%) | |
Female | 295 (56.7%) | 74 (56.5%) | |
Race, n (%) Asian | 6 (1.2%) | 1 (0.8%) | 0.55 |
Black | 55 (10.6%) | 12 (9.2%) | |
White | 441 (84.8%) | 117 (89.3%) | |
Hispanic | 4 (0.8%) | 0 (0%) | |
Unknown | 10 (1.9%) | 0 (0%) | |
Other | 2 (0.4%) | 1 (0.8%) | |
East Indian | 2 (0.4%) | 0 (0%) | |
Insurance, n (%) | 0.017 | ||
Commercial | 20 (3.8%) | 2 (1.5%) | |
Medicare | 213 (41.0%) | 73 (55.7%) | |
Medicaid | 26 (5.0%) | 4 (3.1%) | |
Managed care | 192 (36.9%) | 33 (25.2%) | |
Blue cross | 69 (13.3%) | 19 (14.5%) | |
Tobacco use within past 12 mo, n (%) | 0.08 | ||
Yes | 81 (15.6%) | 11 (8.4%) | |
No | 437 (84.0%) | 120 (91.6%) | |
Unknown | 2 (0.4%) | 0 (0%) | |
Fasting blood glucose (mg/dL), mean (range) | 133.95 (60–303) | 127.84 (79–209) | 0.32 |
Surgeries before index operation (count), mean (range) | |||
Ever | 0.58 (0–12) | 0.61 (0–14) | 0.39 |
90 d Prior | 0.07 (0–5) | 0.02 (0–1) | 0.13 |
Direct cost of operative supplies and implants ($), mean (range) | 10,254 (116–50,894) | 6696 (342–27,592) | <0.001 |
Length of hospital stay (h), mean (range) | 104.64 (24–1070) | 96.59 (26–563) | 0.006 |
Length of follow-up (mo), mean (range) | 43.62 (0.5–83.11) | 38.24 (0.7–80.74) | 0.018 |
Non-neurosurgical operations 30 d after index operation (count), mean (range) | 0.07 (0–3) | 0.09 (0–2) | 0.31 |
Note: Statistically significant (P < 0.05) values are bolded.